Terahertz (THz) radiation underpins many next-generation technologies and advances in materials science, but current THz ...

Company to present at J.P. Morgan Healthcare Conference on Tuesday, Jan 13, 2026 -SAN FRANCISCO--(BUSINESS ...

Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

We're in Las Vegas and here’s just some of the hottest new gear and gadgets we plan to see at this year’s Consumer ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet medical needs, today announced that the U.S. Food and Drug Administration ...

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a stock dividend of one share of common stock for every 1,000 shares of outstanding common stock as well as one share ...

Based on the feedback from the FDA, the Company’s regulatory data package would be sufficient for the submission of an NDA for AXS-12 for the treatment of cataplexy in narcolepsy. Axsome anticipates ...

Terahertz (THz) radiation, which occupies the frequency band between microwaves and infrared light, is essential in many next ...

Multiple clinical data readouts expected in 2026 present opportunity for substantial value creationKOASTAL-2 and -3 on track for consolidated ...

Everyday life is saturated with location-dependent devices. They are multiplying faster than ever and their requirements have ...

Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more about RZLT stock here.